Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2022 16:05 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones

Commenced enrollment in Phase 1 trial with orally administered, broad-spectrum antiviral agent CC-42344 for the treatment of pandemic and seasonal influenza AAdvanced COVID-19 programs with the goal...